Zhitong Finance App News, Zhendong Pharmaceutical (300158.SZ) announced that Guangdong Longchuangji Pharmaceutical Co., Ltd. (“Longchuangji Pharmaceutical”), in which the company is a shareholder, a new drug application (NDA), has been accepted by the Drug Evaluation Center (CDE) of the China National Drug Administration.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Zhendong Pharmaceutical (300158.SZ) announced that Guangdong Longchuangji Pharmaceutical Co., Ltd. (“Longchuangji Pharmaceutical”), in which the company is a shareholder, a new drug application (NDA), has been accepted by the Drug Evaluation Center (CDE) of the China National Drug Administration.